Received Feb 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | M52GG | — |
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
1st Infanrix dose when she was 19 months and 29 days; 11-year-old a Dtap, the Infanrix, she should have gotten the Boostrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old female patient who received DTPa (Infanrix) (batch number M52GG, expiry date 07-SEP-2026) for prophylaxis. Co-suspect products included DTPa (Infanrix) for prophylaxis and DTPa (Reduced antigen) (Boostrix) for prophylaxis. On 06-FEB-2025, the patient received Infanrix. On an unknown date, the patient received the 1st dose of Infanrix and Boostrix. On 06-FEB-2025, an unknown time after receiving Infanrix and not applicable after receiving Infanrix and Boostrix, the patient experienced wrong vaccine administered (Verbatim: 11-year-old a Dtap, the Infanrix, she should have gotten the Boostrix). On an unknown date, the patient experienced inappropriate age at vaccine administration (Verbatim: 1st Infanrix dose when she was 19 months and 29 days). The outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 07-FEB-2025 The health care professional mentioned that the patient received the 1st Infanrix dose when she was 19 months and 29 days, which led inappropriate age at vaccine administration. The nurse reported the patient received Dtap, the Infanrix, she should have gotten the Boostrix the Tdap, which led wrong vaccine administered. The reporter needs to know if she needs to be revaccinated or what recommendations. The reporter consented to follow up.